Technology
Carestream Health’s KODAK DIRECTVIEW CR Mammography feature adds mammography applications to its CR platforms along with ...
October 09, 2007
News
October 10, 2007 - Premier Purchasing Partners, LP, announced new agreements have been awarded for diagnostic imaging ...
October 09, 2007News
October 10, 2007 - A new technique for capturing images of chest veins eases diagnosis of venous diseases, according to ...
October 09, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology
October 9, 2007 - Physio-Control Inc., a wholly owned subsidiary of Medtronic, Inc., will introduce the LUCAS Chest Compression System in the United States through an exclusive distribution partnership with JOLIFE AB, expanding the reach of its emergency medicine device portfolio.
October 08, 2007News
October 9, 2007 – Medtronic Inc. today announced that it has begun enrolling in the PRECEDE-HF clinical trial that will evaluate Medtronic’s proprietary Cardiac Compass and OptiVol Fluid Status Monitoring features to determine whether cardiac trend data may help physicians prevent heart failure hospitalizations or deaths compared to standard clinical assessment alone.
October 08, 2007News
October 9, 2007 - Biophan Technologies Inc., a developer of biomedical technology, announced it has closed the $11 ...
October 08, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
October 9, 2007 - Physio-Control Inc., a wholly owned subsidiary of Medtronic, Inc., today announced that the LUCAS Chest Compression System is available in the U.S. through an exclusive distribution partnership with JOLIFE AB, expanding its reach of its emergency medicine device portfolio.
October 08, 2007News
October 9, 2007 - Ascent Healthcare Solutions announced that the FDA has cleared two Ascent 510(k) submissions to ...
October 08, 2007News
October 9, 2007 - W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the transcatheter closure of atrial septal defect (ASD), providing a percutaneous ASD closure solution for very young patients.
October 08, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
October 9, 2007 - From a snippet of a patient’s skin, researchers have grown blood vessels in a laboratory and then implanted them to restore blood flow around the patient’s damaged arteries and veins.
October 08, 2007News
October 9, 2007 - Medtronic Inc. will provide a synopsis of clinical data on the Endeavor Drug Eluting Coronary Stent to ...
October 08, 2007Technology
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
October 08, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
October 08, 2007News
October 9, 2007 - Luna Innovations Inc. has entered into a joint marketing alliance agreement with Terumo Cardiovascular Systems Corp. (Terumo CVS), in which Luna and Terumo CVS will market Luna’s EDAC (Emboli Detection and Classification) Quantifier, as part of Luna's strategy to expand its presence in the U.S.
October 08, 2007News
October 8, 2007 - Drug-eluting stents were found to be most effective in reducing the need for repeat angioplasty ...
October 07, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now